Cited 65 times in
Amyloid burden, cerebrovascular disease, brain atrophy, and cognition in cognitively impaired patients
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 예병석 | - |
dc.contributor.author | 조한나 | - |
dc.date.accessioned | 2018-03-26T17:10:56Z | - |
dc.date.available | 2018-03-26T17:10:56Z | - |
dc.date.issued | 2015 | - |
dc.identifier.issn | 1552-5260 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/157300 | - |
dc.description.abstract | BACKGROUND: We investigated the independent effects of Alzheimer's disease (AD) and cerebrovascular disease (CVD) pathologies on brain structural changes and cognition. METHODS: Amyloid burden (Pittsburgh compound B [PiB] retention ratio), CVD markers (volume of white matter hyperintensities [WMH] and number of lacunae), and structural changes (cortical thickness and hippocampal shape) were measured in 251 cognitively impaired patients. Path analyses were utilized to assess the effects of these markers on cognition. RESULTS: PiB retention ratio was associated with hippocampal atrophy, which was associated with memory impairment. WMH were associated with frontal thinning, which was associated with executive and memory dysfunctions. PiB retention ratio and lacunae were also associated with memory and executive dysfunction without the mediation of hippocampal or frontal atrophy. CONCLUSIONS: Our results suggest that the impacts of AD and CVD pathologies on cognition are mediated by specific brain regions. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Elsevier | - |
dc.relation.isPartOf | ALZHEIMERS & DEMENTIA | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Aged, 80 and over | - |
dc.subject.MESH | Amyloid/metabolism* | - |
dc.subject.MESH | Aniline Compounds/pharmacokinetics | - |
dc.subject.MESH | Atrophy/etiology | - |
dc.subject.MESH | Brain/diagnostic imaging | - |
dc.subject.MESH | Brain/pathology* | - |
dc.subject.MESH | Cerebrovascular Disorders/complications* | - |
dc.subject.MESH | Cerebrovascular Disorders/diagnostic imaging | - |
dc.subject.MESH | Cognition Disorders/complications* | - |
dc.subject.MESH | Cognition Disorders/diagnostic imaging | - |
dc.subject.MESH | Cognition Disorders/metabolism | - |
dc.subject.MESH | Cognition Disorders/pathology* | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Image Processing, Computer-Assisted | - |
dc.subject.MESH | Magnetic Resonance Imaging | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Mental Status Schedule | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Neuropsychological Tests | - |
dc.subject.MESH | Positron-Emission Tomography | - |
dc.subject.MESH | Retrospective Studies | - |
dc.subject.MESH | Thiazoles/pharmacokinetics | - |
dc.title | Amyloid burden, cerebrovascular disease, brain atrophy, and cognition in cognitively impaired patients | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine | - |
dc.contributor.department | Dept. of Neurology | - |
dc.contributor.googleauthor | Byoung Seok Ye | - |
dc.contributor.googleauthor | SangWon Seo | - |
dc.contributor.googleauthor | Geon Ha Kim | - |
dc.contributor.googleauthor | Young Noh | - |
dc.contributor.googleauthor | Hanna Cho | - |
dc.contributor.googleauthor | Cindy W. Yoon | - |
dc.contributor.googleauthor | Hee Jin Kim | - |
dc.contributor.googleauthor | Juhee Chin | - |
dc.contributor.googleauthor | Seun Jeon | - |
dc.contributor.googleauthor | Jong Min Lee | - |
dc.contributor.googleauthor | Joon-Kyung Seong | - |
dc.contributor.googleauthor | Jae Seung Kim | - |
dc.contributor.googleauthor | Jae-Hong Lee | - |
dc.contributor.googleauthor | Yearn Seong Choe | - |
dc.contributor.googleauthor | Kyung Han Lee | - |
dc.contributor.googleauthor | Young H. Sohn | - |
dc.contributor.googleauthor | Michael Ewersl | - |
dc.contributor.googleauthor | Michael Weiner | - |
dc.contributor.googleauthor | Duk L. Na | - |
dc.identifier.doi | 10.1016/j.jalz.2014.04.521 | - |
dc.contributor.localId | A04603 | - |
dc.contributor.localId | A03920 | - |
dc.relation.journalcode | J00068 | - |
dc.identifier.eissn | 1552-5279 | - |
dc.identifier.pmid | 25048578 | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S1552526014024194 | - |
dc.subject.keyword | Amyloid | - |
dc.subject.keyword | Atrophy | - |
dc.subject.keyword | Cerebrovascular disease | - |
dc.subject.keyword | Cognition | - |
dc.subject.keyword | Cortical thickness | - |
dc.subject.keyword | Hippocampus | - |
dc.subject.keyword | Path analysis | - |
dc.subject.keyword | Pittsburgh compound B | - |
dc.contributor.alternativeName | Ye, Byoung Seok | - |
dc.contributor.alternativeName | Cho, Hanna | - |
dc.contributor.affiliatedAuthor | Ye, Byoung Seok | - |
dc.contributor.affiliatedAuthor | Cho, Hanna | - |
dc.citation.volume | 11 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 494 | - |
dc.citation.endPage | 503 | - |
dc.identifier.bibliographicCitation | ALZHEIMERS & DEMENTIA, Vol.11(5) : 494-503, 2015 | - |
dc.identifier.rimsid | 52493 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.